Paper7686816
Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M and 6 others. Cancer Res, 1993. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Papers, record 7686816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7686816
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Antigens, Differentiation, T-Lymphocyte | Major topic |
| Cell Adhesion Molecules | Major topic |
| Melanoma | Major topic |
| Membrane Glycoproteins | Major topic |
| Receptors, Immunologic | Major topic |
| CD11 Antigens | |
| CD2 Antigens | |
| CD58 Antigens | |
| Cytokines | |
| Humans | |
| Intercellular Adhesion Molecule-1 | |
| Killer Cells, Lymphokine-Activated | |
| Killer Cells, Natural | |
| Lymphocytes, Tumor-Infiltrating | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA39559 | NCI NIH HHS | United States | R01CA039559 | PubMed and NIH |
Source NIH RePORTER
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40955371 | The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets. | Onco Targets Ther | 2025 | https://conductscience.org/library/papers/40955371 | PubMed |
| 40897749 | Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion. | Sci Data | 2025 | https://conductscience.org/library/papers/40897749 | PubMed |
| 39953610 | Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/39953610 | PubMed |
| 39368806 | Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism. | Blood Adv | 2025 | https://conductscience.org/library/papers/39368806 | PubMed |
| 38510242 | Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. | Front Immunol | 2024 | https://conductscience.org/library/papers/38510242 | PubMed |
| 34682791 | Hodgkin Lymphoma: A Special Microenvironment. | J Clin Med | 2021 | https://conductscience.org/library/papers/34682791 | PubMed |
| 34193136 | Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34193136 | PubMed |
| 32444628 | Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32444628 | PubMed |
| 31795829 | Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells. | Int J Hyperthermia | 2019 | https://conductscience.org/library/papers/31795829 | PubMed |
| 30581389 | Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30581389 | PubMed |
| 29772648 | Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture. | Cells | 2018 | https://conductscience.org/library/papers/29772648 | PubMed |
| 29707134 | A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies. | Oncotarget | 2018 | https://conductscience.org/library/papers/29707134 | PubMed |
| 29245925 | Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/29245925 | PubMed |
| 28554945 | Genetic background and evolution of relapses in aggressive B-cell lymphomas. | Haematologica | 2017 | https://conductscience.org/library/papers/28554945 | PubMed |
| 26513172 | Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1. | Oncotarget | 2015 | https://conductscience.org/library/papers/26513172 | PubMed |
| 24535541 | Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma. | J Mol Histol | 2014 | https://conductscience.org/library/papers/24535541 | PubMed |
| 23138873 | Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide. | Cancer Immunol Immunother | 2013 | https://conductscience.org/library/papers/23138873 | PubMed |
| 23006327 | Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. | J Clin Invest | 2012 | https://conductscience.org/library/papers/23006327 | PubMed |
| 22950745 | Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. | J Transl Med | 2012 | https://conductscience.org/library/papers/22950745 | PubMed |
| 22137796 | Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. | Cancer Cell | 2011 | https://conductscience.org/library/papers/22137796 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD2 | 914 | PubTator's text mining | https://conductscience.org/library/genes/914 | NCBI Gene |
| CD58 | 965 | PubTator's text mining | https://conductscience.org/library/genes/965 | NCBI Gene |
| ICAM1 | 3383 | PubTator's text mining | https://conductscience.org/library/genes/3383 | NCBI Gene |
| ITGAL | 3683 | PubTator's text mining | https://conductscience.org/library/genes/3683 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7686816
GET https://conductscience.org/api/papers/v1/7686816/cited_by?page=2